AJCN EB Program 2010
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nilausen, K.
Right arrow Articles by Meinertz, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nilausen, K.
Right arrow Articles by Meinertz, H.
Agricola
Right arrow Articles by Nilausen, K.
Right arrow Articles by Meinertz, H.
American Journal of Clinical Nutrition, Vol. 69, No. 3, 419-425, March 1999
© 1999 American Society for Clinical Nutrition


Original Research Communications

Lipoprotein(a) and dietary proteins: casein lowers lipoprotein(a) concentrations as compared with soy protein1,2,3

Karin Nilausen and Hans Meinertz

Background: Substitution of soy protein for casein in the diet decreases LDL cholesterol and increases HDL cholesterol. How the 2 proteins affect lipoprotein(a) [Lp(a)], an independent risk factor for coronary artery disease, is unknown.

Objective: We compared the effects of dietary soy protein and casein on plasma Lp(a) concentrations.

Design: Nine normolipidemic men were studied initially while consuming their habitual, self-selected diets, and then, in a crossover design, while consuming 2 liquid-formula diets containing either casein or soy protein. The dietary periods lasted 45 d (n = 7) or 33 d (n = 2). Fasting total cholesterol, LDL-cholesterol, HDL-cholesterol, triacylglycerol, and Lp(a) concentrations were measured throughout.

Results: After 30 d of each diet, the mean concentration of Lp(a) was not significantly different after the soy-protein and self-selected diets. However, Lp(a) decreased by an average of 50% (P < 0.001) after the casein diet as compared with concentrations after both the soy-protein and self-selected diets. Two weeks after subjects switched from the self-selected to the soy-protein diet, Lp(a) increased by 20% (P = 0.065), but subsequently decreased to baseline. In contrast, the switch to the casein diet did not cause an increase in Lp(a), but instead a continuing decrease in mean concentrations to 65% below baseline (P < 0.0002). Total cholesterol, LDL cholesterol, and HDL cholesterol were significantly lower >=30 d after both the casein and soy-protein diets than after the self-selected diet (P < 0.001). HDL cholesterol was 11% higher after the soy-protein diet than after the casein diet (P < 0.002), but LDL cholesterol, total cholesterol, and triacylglycerol were not significantly different after the casein and soy-protein diets.

Conclusion: These findings indicate that soy protein may have an Lp(a)-raising effect, potentially detrimental to its use in antiatherogenic diets.

Key Words: Lipoprotein(a) • plasma lipoproteins • dietary proteins • soy protein • casein • liquid-formula diets • coronary artery disease • men • Denmark




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. M. Sacks, A. Lichtenstein, L. Van Horn, W. Harris, P. Kris-Etherton, M. Winston, and for the AHA Nutrition Committee
Soy protein, isoflavones, and cardiovascular health: a summary of a statement for professionals from the american heart association nutrition committee.
Arterioscler Thromb Vasc Biol, August 1, 2006; 26(8): 1689 - 1692.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
W. L Hall, K. Vafeiadou, J. Hallund, S. Bugel, M. Reimann, C. Koebnick, H-J F. Zunft, M. Ferrari, F. Branca, T. Dadd, et al.
Soy-isoflavone-enriched foods and markers of lipid and glucose metabolism in postmenopausal women: interactions with genotype and equol production
Am. J. Clinical Nutrition, March 1, 2006; 83(3): 592 - 600.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. M. Sacks, A. Lichtenstein, L. Van Horn, W. Harris, P. Kris-Etherton, M. Winston, and for the American Heart Association Nutrition Commi
Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals From the Nutrition Committee
Circulation, February 21, 2006; 113(7): 1034 - 1044.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. L McVeigh, B. L Dillingham, J. W Lampe, and A. M Duncan
Effect of soy protein varying in isoflavone content on serum lipids in healthy young men
Am. J. Clinical Nutrition, February 1, 2006; 83(2): 244 - 251.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
S. Tonstad, K. Smerud, and L. Hoie
A comparison of the effects of 2 doses of soy protein or casein on serum lipids, serum lipoproteins, and plasma total homocysteine in hypercholesterolemic subjects
Am. J. Clinical Nutrition, July 1, 2002; 76(1): 78 - 84.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Meinertz, K. Nilausen, and J. Hilden
Alcohol-Extracted, but Not Intact, Dietary Soy Protein Lowers Lipoprotein(a) Markedly
Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 312 - 316.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. J. Teede, F. S. Dalais, D. Kotsopoulos, Y.-L. Liang, S. Davis, and B. P. McGrath
Dietary Soy Has Both Beneficial and Potentially Adverse Cardiovascular Effects: A Placebo-Controlled Study in Men and Postmenopausal Women
J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3053 - 3060.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by The American Society for Nutrition